Tonapofylline
- Generic Name
- Tonapofylline
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H32N4O4
- CAS Number
- 340021-17-2
- Unique Ingredient Identifier
- 83VNU4U44T
- Background
Tonapofylline has been used in trials studying the treatment of Heart Failure, Renal Insufficiency, and Congestive Heart Failure.
- Associated Conditions
- -
- Associated Therapies
- -
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Biogen
- Target Recruit Count
- 34
- Registration Number
- NCT00745316
Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Biogen
- Target Recruit Count
- 420
- Registration Number
- NCT00709865
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath